<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004189A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004189</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13976570</doc-number><date>20120125</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><priority-claims><priority-claim sequence="01" kind="national"><country>IN</country><doc-number>220/MUM/2011</doc-number><date>20110125</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>13</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>9</main-group><subgroup>48</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>9</main-group><subgroup>28</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>13</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>9</main-group><subgroup>28</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>9</main-group><subgroup>4808</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>424459</main-classification><further-classification>514662</further-classification><further-classification>424471</further-classification><further-classification>427  221</further-classification></classification-national><invention-title id="d0e61">MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS MEMANTINE</invention-title><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Roy</last-name><first-name>Sunilendu Bhushan</first-name><address><city>Gujarat</city><country>IN</country></address></addressbook><residence><country>IN</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Kulkarni</last-name><first-name>Sushrut Krishnaji</first-name><address><city>Gujarat</city><country>IN</country></address></addressbook><residence><country>IN</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Shenoy</last-name><first-name>Sandhya Rajendra</first-name><address><city>Gujarat</city><country>IN</country></address></addressbook><residence><country>IN</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Ghogari</last-name><first-name>Imran Shakoor</first-name><address><city>Gujarat</city><country>IN</country></address></addressbook><residence><country>IN</country></residence></us-applicant><us-applicant sequence="04" app-type="applicant" designation="us-only"><addressbook><last-name>Patil</last-name><first-name>Vijaykumar Shivajrao</first-name><address><city>Gujarat</city><country>IN</country></address></addressbook><residence><country>IN</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Roy</last-name><first-name>Sunilendu Bhushan</first-name><address><city>Gujarat</city><country>IN</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Kulkarni</last-name><first-name>Sushrut Krishnaji</first-name><address><city>Gujarat</city><country>IN</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Shenoy</last-name><first-name>Sandhya Rajendra</first-name><address><city>Gujarat</city><country>IN</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Ghogari</last-name><first-name>Imran Shakoor</first-name><address><city>Gujarat</city><country>IN</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Patil</last-name><first-name>Vijaykumar Shivajrao</first-name><address><city>Gujarat</city><country>IN</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>CADILA HEALTHCARE LIMITED</orgname><role>03</role><address><city>Ahmedabad</city><country>IN</country></address></addressbook></assignee></assignees><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/IN2012/000054</doc-number><kind>00</kind><date>20120125</date></document-id><us-371c124-date><date>20130918</date></us-371c124-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">Modified release pharmaceutical compositions of memantine or pharmaceutically acceptable salts thereof are described. The compositions of invention are stable, possess improved formulation characteristics and also provide extended therapeutically effective plasma levels over a twenty four hours period. Processes of making these compositions are also described.</p></abstract></us-patent-application>